in Newswire Published on March 30, 2021

Class Action Seeks Refunds for ‘Worthless’ Picato Gel Linked to Increased Skin Cancer Risk

Kamlade v. Leo Pharma Inc. et al.

Filed: March 29, 2021 § 1:21-cv-00522

A class action seeks refunds for consumers who bought LEO Pharma’s now-discontinued Picato gel that’s been linked to an increased risk of squamous cell skin cancer.




Case Spotlight

Camp Lejeune Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on March 30, 2021 — 5:02 PM

Corrado Rizzi

Corrado Rizzi is the Senior Managing Editor of

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.